logo
episode-header-image
Apr 2024
19m 57s

T-Cell Malignant Neoplasms After Chimeri...

JAMA NETWORK
About this episode
tail spinning
Up next
Nov 26
Metastatic Recurrence Among Adolescents and Young Adults With Cancer
tail spinning
11m 52s
Oct 2025
Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality
Interview with Yiwen Zhang, PhD, and Edward L. Giovannucci, MD, ScD, authors of Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality. Hosted by Vivek Subbiah, MD. Related Content: Consistent Adherence to Physical Activity Guidelines ... Show More
12m 29s
Sep 2025
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer 
13m 26s
Recommended Episodes
Oct 2024
Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction
Interview with S. A. Reza Nouraei, BChir, PhD, author of Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction—The Overwhelmed Vagus Hypothesis. Hosted by Paul C. Bryson, MD, MBA. Related Content: Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfuncti ... Show More
13m 19s
Apr 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More
12m 19s
Jul 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ... Show More
17m 45s
Dec 2023
A natural history of familial platelet disorder with myeloid malignancy; HEXIM1 as an essential transcription regulator in erythropoiesis; residual disease predicts relapse in CML patients
In this week's episode we’ll discuss the findings from a natural history study of patients with familial platelet disorder with myeloid malignancy, learn more about the role of HEXIM1 as an essential transcription regulator in human erythropoiesis, and discuss the utility of resi ... Show More
21m 53s
Sep 2023
Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction 
14m 21s
Feb 2025
Manual Therapy for Fibrosis-Related Late Effect Dysphagia in HNC Survivors
Interview with Katherine A. Hutcheson, PhD, author of Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Manual Therapy for Fibrosis-Related Late ... Show More
19m 35s
Aug 2025
Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia
Interview with Nyssa Fox Farrell, MD, and Lara W. Crock, MD, PhD, MSCI, authors of Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Stellate Ganglion Block for the Treatment of ... Show More
19m 42s
Nov 2023
S2 Episode 6: Rare Disease: Is It Membranous Nephropathy?
Join experts Drs Matthew Sparks and Laurence Beck as they discuss the diagnosis and management of membranous nephropathy, a rare kidney disease. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991606). The topics and ... Show More
29m 23s
Nov 6
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More
9m 36s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
<p>CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott ... Show More
18m 22s